| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086085A1 INHIBITORS OF p38 |
| 03/28/2001 | EP1086084A1 Tetraisoquinololine derivatives as modulators of dopamine d3 receptors |
| 03/28/2001 | EP1086083A1 Protease inhibitors |
| 03/28/2001 | EP1086082A1 Arylsubstituted olefinic amines and their use as cholinergic receptors agonists |
| 03/28/2001 | EP1086081A1 Quarternary ammonium compounds as anti-tussive agents |
| 03/28/2001 | EP1086080A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 03/28/2001 | EP1086079A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids |
| 03/28/2001 | EP1086078A1 Neuropeptide y5 receptor antagonists |
| 03/28/2001 | EP1086077A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 03/28/2001 | EP1086071A1 Hyperforin derivatives, the use thereof and formulations containing them |
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086063A1 Novel potassium channel drugs and their uses |
| 03/28/2001 | EP1085921A2 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems |
| 03/28/2001 | EP1085920A1 Dextrin-containing composition for preventing surgical adhesions |
| 03/28/2001 | EP1085907A1 Solution comprising prostaglandins and benzyl alcohol |
| 03/28/2001 | EP1085895A1 Bradykinin antagonists |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085888A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht 3? receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085886A1 Protecting neurons from ischemia |
| 03/28/2001 | EP1085884A1 Combination of compounds containing selenium and cytostatic agents |
| 03/28/2001 | EP1085883A1 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases |
| 03/28/2001 | EP1085881A1 Pharmaceutical compositions containing alpha-tocopherylphosphocholine |
| 03/28/2001 | EP1085880A2 Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells |
| 03/28/2001 | EP1085878A2 Use of aminosterol derivatives as chloride ionophores |
| 03/28/2001 | EP1085877A1 Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma |
| 03/28/2001 | EP1085876A1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 03/28/2001 | EP1085875A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders |
| 03/28/2001 | EP1085874A1 Use of a nk-1 receptor antagonist for treating sexual dysfunctions |
| 03/28/2001 | EP1085873A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders |
| 03/28/2001 | EP1085872A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-$g(k)B |
| 03/28/2001 | EP1085871A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085869A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085867A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 03/28/2001 | EP1085866A1 Use of benzomorphan derivatives as an analgesic |
| 03/28/2001 | EP1085865A1 Use of cytoprotectants |
| 03/28/2001 | EP1085864A1 Method of hiv and hpv prophylaxis |
| 03/28/2001 | EP1085863A1 Cross-reference to related applications |
| 03/28/2001 | EP1085862A1 Method of treating an autoimmune disorder |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085860A1 Formulations for the treatment of gastro-oesophageal reflux |
| 03/28/2001 | EP1085859A1 Wound treatment through inhibition of adenosine diphosphate ribosyl transferase |
| 03/28/2001 | EP1085858A2 Transdermal therapeutic system for the administration of candesartan |
| 03/28/2001 | EP1085857A2 Cationic amphiphile micellar complexes |
| 03/28/2001 | EP1085856A2 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist |
| 03/28/2001 | EP1085855A1 Enhanced intra vaginal devices |
| 03/28/2001 | EP1085854A1 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses |
| 03/28/2001 | EP1085853A1 Heterocyclic ester and amide hair growth compositions and uses |
| 03/28/2001 | EP1085848A2 Inhibitors of transcription factor nf-kappa b |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | EP1085804A1 Method and composition for the treatment of epidermal irritations and infections |
| 03/28/2001 | EP0921796B1 Tetrahydrolipstatin containing compositions |
| 03/28/2001 | EP0910428A4 Photopheresis treatment of chronic hcv infections |
| 03/28/2001 | EP0876330B1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 03/28/2001 | EP0842178B1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 03/28/2001 | EP0820446A4 Synthesis of bis-indolylmaleimides |
| 03/28/2001 | EP0775132B1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 03/28/2001 | EP0767800B1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 03/28/2001 | EP0759087B1 Compositions and methods for targeting gene delivery vehicles |
| 03/28/2001 | EP0742714B1 Liquid pharmaceutical compositions comprising thyroid hormones |
| 03/28/2001 | EP0732922B1 Transdermal delivery device |
| 03/28/2001 | EP0725638B1 Treatment of laminitis |
| 03/28/2001 | EP0721330B1 Pharmaceutical composition |
| 03/28/2001 | EP0719097B1 Novel dietetic phospholipid compositions and use thereof as a dietary supplement |
| 03/28/2001 | EP0674635B1 Quinuclidine derivatives as squalene synthase inhibitors |
| 03/28/2001 | CN1289371A Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications |
| 03/28/2001 | CN1289338A 2-(purin-9-yl)-tetahydrofuran-3,4-diol derivatives |
| 03/28/2001 | CN1289336A Chemokine receptor antagonists and methods of use therefor |
| 03/28/2001 | CN1289335A Azolo triazizes and pyrimidines |
| 03/28/2001 | CN1289334A Benzothiadiazoles and derivatives |
| 03/28/2001 | CN1289333A Oxazole derivatives as serotonin-1A receptor ogonists |
| 03/28/2001 | CN1289332A 1,4-Diazacycloheptane derivatives for the treatment of neurological disorders |
| 03/28/2001 | CN1289331A Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 03/28/2001 | CN1289326A N-[(substituted five-membered di-or thiaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia |
| 03/28/2001 | CN1289323A Matrix metalloproteinase inhibitors |
| 03/28/2001 | CN1289322A Hydroxamic and carboxylic acid derivatives |
| 03/28/2001 | CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 03/28/2001 | CN1289319A Diterpene derivatives and anti-inflammatory analgesic agents comprising the same |
| 03/28/2001 | CN1289254A Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 03/28/2001 | CN1289251A synergistic mixtures of natural products |
| 03/28/2001 | CN1289250A Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 03/28/2001 | CN1289249A Derivatives of 1,3,4-oxadiazolone |
| 03/28/2001 | CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 03/28/2001 | CN1289246A Antiplaque oral composition and method |
| 03/28/2001 | CN1288899A Selenium compound of polysaccharide and its preparation |
| 03/28/2001 | CN1288896A Quercetin derivative and its medicinal use |
| 03/28/2001 | CN1288892A Preparation and application of dihydromyricetrin |
| 03/28/2001 | CN1288890A Water soluble taxad alcohol derivative |
| 03/28/2001 | CN1288885A Alkylating method of hindered sulfonic acid |
| 03/28/2001 | CN1288753A Dermatosis treating ointment |